Yoseph Aditya 22010110110032 BAB8KTI
DAFTAR PUSTAKA
1. Alatas H, Tambunan T, Trihono P, Pardede SO. Konsensus Tatalaksana
Sindrom Nefrotik Idiopatik pada Anak. Jakarta. Indonesia:2005.
2. Gbadegesin R, Smoyer WE. Dalam: Denis F, Geary, Franz Schaefer,
penyunting. Comprhensive pediatric nephrology. China: Gearysch mosby;
2008. h.205
3. Lane JC. Nephrotic syndrome [serial online]. 12 Mei 2010 [cited 7 Februari
2014].
Didapat
dari:
www.emedicine.medscape.com/article/9892920-
overview
4. Wiguno Prodjosujadi, Divisi Ginjal Hipertensi. Buku Ajar Ilmu Penyakit
Dalam . edisi 4. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam
Fakultas Kedokteran Universitas Indonesia; 2006.
5. Sukandar E, Sulaeman R. Ilmu Penyakit Dalam Jilid II. Jakarta: Balai
Penerbit FKUI;1990. p. 282-305.
6. Orth SR, Ritz E. The Nephrotic Syndrome. N Engl.Med 1998;338:1201-12.
7. Varni J.W., Seid M, Rode C.A. The PedsQLTM measurement model for the
pediatric quality of life inventory.PubMed.1999; 37(2):126-39. Available
from www.ncbi.nlm.nih.gov/pubmed/10024117
70
71
8. Clark A.G, Barratt T.M. Steroid responsive nephrotic syndrome. Dalam: Pine
J.W., penyunting. Pediatric Nephrology. United States of America: Lippincott
Williams&Wilkins; 1999.h.731-45.
9. Otukesh H, Otukesh S, Mojtahedzadeh M, Hoseini R, Fereshtehnejad S.M.,
Riahi A.F. et.al. Management and outcome of steroid-resistant nephrotic
syndrome in children.2009 [cited 24 Januari 2014]. Available from:
http://translate.google.co.id/translate?hl=id&langpair=en|id&u=http://www.ijk
d.org/index.php/ujkd/article/viewFile/122/129
10. Nachman Patrick H, Jannette Charles J., Falk Ronald J. Primary Glomerular
Disease. In: Brenner, Barry M, editors. The Kidney 8th Edition volume 1.
Philadelphia: Saunders Elsevier;2008. p. 1000-03, 1019-28.
11. Wila WIrya IG. Sindrom Nefrotik. Dalam Alatas H, Tambunan T, Trihono P,
Pardede SO. Buku Ajar Nefrologi Anak. Edisi Kedua. Jakarta: Balai Penerbit
FKUI; 2002. h.381-91, 410-22.
12. Appel GB. Glomeruler Disorders and Nephrotic Syndromes. In:Goldman L,
Ausiello D,eds.Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders
Elxevier.2007: chap 122.
13. Kumar Vinay, Cotran Ranzi S., Robbins Stanley L. Buku Ajar Patologi
Volume 2. Edisi 7. Jakarta: Penerbit Buku Kedokteran EGC; 2010.
14. Wijaya Indra, Miranti Ika Pawitra. Patologi Ginjal dan Saluran Kemih.
Semarang: Bagian Patologi Anatomi FK UNDIP;2001.
72
15. Bahiense, Oliviera M, Saldanha LB, Andrade Mota El, et.al. Primary
Glomerular Disease in Brazil: 1979-1999. Is The Frequency of FSGS
increasing? Clin Nephrology. 2004;61: 90-7.
16. Kitiyakana C, Eggers P, Kopp JB. 21 year trend in ESRD due to FSGS in The
United States. Am J Kidney Dis. 2004;44: 815-25.
17. Batinic Danko, Milosevic Danko, Coric Marijana, Scukanec-Spoljar Mira,
Konjevoda Pasko, Batinic Danica et.al. Idiopathic nephritic syndrome in
children: review of 282 Croatian cases. Clinical Nephrology. 2012 ; vol.78No. 2/2012(116-21). Available from: www.dustri.com/nc/article
18. Kanemoto Katsuyoshi, Ito Hidekazu, Anzai Michiko, Matsumura Chieko,
Kurayama Hideaki et.al. Clinical significance of IgM and C1q deposition in
the mesangium in pediatric idiopathic nephritic syndrome. JNephrology.
2013; 26(02):306-14. Available from: www.jnephrol.com/article/clinical-sign
19. D’Agati V. Focal Segmental Glomerulosclerosis. In: D’Agati V, Jannette JC,
Siva FS, eds. Atlas of Non-Tumor Pathology: Nonneoplastic Kidney Disease.
Silver Springer, Md: American Registry of Pathology Brees, 2005: 125-59.
20. Haas M, Maehan S, Karrion TG, Spargo BH. Changing Etiologies of
unexplained adult Nephrotic Syndrome: A Comparison of Renal Biopsy
Finding From 1976-1979 and 1995-1997. Am J Kidney Dis.1997;30:621-31.
21. Aggarwal N, Appel GB. Focal Segmental Glomerulosclerosis. In: Greenberg
A, ed.Primer on Kidney Disease. 5th ed., Philadelphia: WB: Saunder;2009:
165-70.
73
22. Ahmadzedah A, Derakhsan A, Hakimzadeh M, Zolfigol A. Idiopathic
Nephrotic Syndrome in Iranian Children. Indian Pediatrics 2008; 45;52-3.
23. Nasution A., Aumas P. Gambaran Klinis Laboratorium dan Hasil Pengobatan
Sindrom Nefrotik Pada Anak yang dirawat di bagian IKA RSUP Dr. M.
Djamil Padang periode 1997-2000. Disampaikan pada KONIKA XII Bali:
Ikatan Dokter Anak Indonesia;2001.
24. Nilawati G.A.P. Profil Sindrom Nefrotik pada Ruang Perawatan Anak RSUP
Sanglah Denpasar. Denpasar : Departemen Ilmu Kesehatan Anak Fakultas
Kedokteran Universitas Udayana;2012.
25. NiaudetP. Steroid-sensitive idiopathic nephritic syndrome. Dalam: Avner ED,
Harmon WE, NIaudet P. Pediatric nephrology. Edisi ke-5. Philadelphia:
Lippincott Williams&Wilkins;2004.h.545-73.
26. Okoro BA, Okafur HU. Childhood nephrotic syndrome in Enugu, Nigeria.
West Afr J Med 2000; 19:137-41.
74
DAFTAR TILIK PENELUSURAN REKAM MEDIK
Tabel 5. Daftar Tilik Penelusuran Rekam Medik
No.
Keterangan
1.
Nama
2.
Jenis Kelamin
3.
Umur
4.
Berat Badan
5.
Tinggi Badan
6.
Tekanan Darah
140/90
(+)3
(+)4
(+)3
(+)4
75
15.
Hasil Biopsi
76
77
78
79
80
Spreadsheet Data
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Jenis
Kelamin
L
P
L
P
L
P
P
L
P
L
L
P
P
P
L
L
L
P
L
L
P
P
L
L
L
L
L
P
L
L
L
TD
(mmHg)
Chol.
(mg/dl)
TG
(mg/dl)
Ggn Lap
Pandang
ISPA
Biopsi
110/60
160/90
115/70
110/80
100/60
120/90
110/80
90/60
120/80
140/100
115/75
150/110
100/70
130/80
114/60
160/100
160/100
117/79
110/70
110/70
110/70
100/60
90/50
110/70
90/50
120/87
100/60
90/60
100/60
120/80
100/65
>200
>200
>200
>200
>200
>200
>200
>200
>200
>200
>200
>200
>200
>200
>200
>200
150-199
>200
>200
150-199
>200
150-199
>200
150-199
200
>200
>200
>200
>200
>200
>200
>200
>200
>200
>200
150-199
150-199
200
200
150-199
>200
>200
150-199
150-199
150-199
3
3
3
150/100
4
12.9
12.9
100.0
31
100.0
100.0
Total
Cholesterol
Cumulative
Frequency
Valid
Percent
Valid Percent
Percent
< 200 mg/dl
1
3.2
3.2
3.2
> 200 mg/dl
30
96.8
96.8
100.0
Total
31
100.0
100.0
TG
Cumulative
Frequency
Valid
200 mg/dl
12
38.7
38.7
Total
31
100.0
100.0
100.0
Prot.Urin
Cumulative
Frequency
Valid
Percent
Valid Percent
Percent
+1
2
6.5
6.5
6.5
+2
3
9.7
9.7
16.1
+3
14
45.2
45.2
61.3
+4
12
38.7
38.7
100.0
Total
31
100.0
100.0
Albumin
Cumulative
Frequency
Percent
Valid Percent
Percent
86
Albumin
Cumulative
Frequency
Valid
< 3,5 g/dl
Percent
31
Valid Percent
100.0
Percent
100.0
100.0
Hematuria
Cumulative
Frequency
Valid
Negatif
Percent
Valid Percent
Percent
23
74.2
74.2
74.2
+1
1
3.2
3.2
77.4
+2
4
12.9
12.9
90.3
+3
2
6.5
6.5
96.8
+4
1
3.2
3.2
100.0
31
100.0
100.0
Total
Edema
Cumulative
Frequency
Valid
Ya
31
Percent
100.0
Valid Percent
100.0
Percent
100.0
87
Ggn.LapangPandang
Cumulative
Frequency
Valid
Tidak
Valid Percent
Percent
27
87.1
87.1
87.1
4
12.9
12.9
100.0
31
100.0
100.0
Ya
Total
Percent
ISNA
Cumulative
Frequency
Valid
Tidak
Valid Percent
Percent
25
80.6
80.6
80.6
6
19.4
19.4
100.0
31
100.0
100.0
Ya
Total
Percent
Biopsi
Cumulative
Frequency
Valid
Percent
Valid Percent
Percent
Minimal Change Disease
3
9.7
9.7
9.7
Nefropati Membranosa
3
9.7
9.7
19.4
88
Focal Segmental
23
74.2
74.2
93.5
2
6.5
6.5
100.0
31
100.0
100.0
Glomerulosclerosis
Membrano Proliferative
Glomerulonephritis
Total
89
Crosstabs
Case Processing Summary
Cases
Valid
N
Missing
Percent
N
Total
Percent
N
Percent
Jenis Kelamin * Biopsi
31
100.0%
0
.0%
31
100.0%
Umur * Biopsi
31
100.0%
0
.0%
31
100.0%
Tekanan Darah * Biopsi
31
100.0%
0
.0%
31
100.0%
Cholesterol * Biopsi
31
100.0%
0
.0%
31
100.0%
TG * Biopsi
31
100.0%
0
.0%
31
100.0%
Prot.Urin * Biopsi
31
100.0%
0
.0%
31
100.0%
Albumin * Biopsi
31
100.0%
0
.0%
31
100.0%
Hematuria * Biopsi
31
100.0%
0
.0%
31
100.0%
Edema * Biopsi
31
100.0%
0
.0%
31
100.0%
Ggn.LapangPandang * Biopsi
31
100.0%
0
.0%
31
100.0%
ISNA * Biopsi
31
100.0%
0
.0%
31
100.0%
Jenis Kelamin * Biopsi
90
Crosstab
Biopsi
Minimal
Jenis Kelamin
Laki-Laki
Change
Nefropati
Disease
Membranosa
Count
% of Total
Perempuan
Count
% of Total
Total
Count
% of Total
Proliferative
rosis
hritis
Total
1
16
1
19
3.2%
3.2%
51.6%
3.2%
61.3%
2
2
7
1
12
6.5%
6.5%
22.6%
3.2%
38.7%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
df
sided)
Pearson Chi-Square
2.748a
3
.432
Likelihood Ratio
2.703
3
.440
Linear-by-Linear Association
1.388
1
.239
31
Segmental
1
Asymp. Sig. (2-
N of Valid Cases
Membrano
Glomeruloscle Glomerulonep
Chi-Square Tests
Value
Focal
91
Chi-Square Tests
Asymp. Sig. (2Value
df
sided)
Pearson Chi-Square
2.748a
3
.432
Likelihood Ratio
2.703
3
.440
Linear-by-Linear Association
1.388
1
.239
N of Valid Cases
31
a. 6 cells (75.0%) have expected count less than 5. The minimum expected
count is .77.
Umur * Biopsi
Crosstab
Biopsi
Focal
Membrano
Segmental Proliferative
Nefropati Glomerulosc Glomerulone
Membranosa
lerosis
phritis
Minimal
Change
Disease
Umur 1-10 tahun Count
% of
Total
11-20
tahun
Count
% of
Total
Total
2
0
13
1
16
6.5%
.0%
41.9%
3.2%
51.6%
1
3
6
0
10
3.2%
9.7%
19.4%
.0%
32.3%
92
21-30
tahun
Count
% of
Total
31-40
tahun
Count
% of
Total
41-50
tahun
Count
% of
Total
51-60
tahun
Count
% of
Total
Total
Count
% of
Total
0
0
1
0
1
.0%
.0%
3.2%
.0%
3.2%
0
0
1
1
2
.0%
.0%
3.2%
3.2%
6.5%
0
0
1
0
1
.0%
.0%
3.2%
.0%
3.2%
0
0
1
0
1
.0%
.0%
3.2%
.0%
3.2%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
Chi-Square Tests
Asymp. Sig. (2Value
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear Association
df
sided)
14.441a
15
.492
12.725
15
.623
.660
1
.417
93
N of Valid Cases
31
a. 22 cells (91.7%) have expected count less than 5. The minimum expected
count is .06.
Tekanan Darah * Biopsi
Crosstab
Biopsi
Minimal
Tekanan Darah 120/80
Count
% of
Focal
Membrano
Segmental
Proliferative
Change
Nefropati
Glomeruloscl
Glomerulonep
Disease
Membranosa
erosis
hritis
Total
3
2
17
1
23
9.7%
6.5%
54.8%
3.2%
74.2%
0
0
3
0
3
.0%
.0%
9.7%
.0%
9.7%
0
0
0
1
1
.0%
.0%
.0%
3.2%
3.2%
0
1
3
0
4
Total
120-139/80-89 Count
% of
Total
140-149/90-99 Count
% of
Total
>150/100
Count
94
% of
.0%
3.2%
9.7%
.0%
12.9%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
Total
Total
Count
% of
Total
Chi-Square Tests
Asymp. Sig. (2Value
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear Association
N of Valid Cases
df
sided)
17.610a
9
.040
9.681
9
.377
.466
1
.495
31
a. 15 cells (93.8%) have expected count less than 5. The minimum expected
count is .06.
Cholesterol * Biopsi
Crosstab
95
Biopsi
Focal
Minimal
Cholesterol
< 200 mg/dl
Segmental
Proliferative
Change
Nefropati
Glomeruloscle
Glomerulonep
Disease
Membranosa
rosis
hritis
Count
1
0
0
1
.0%
3.2%
.0%
.0%
3.2%
3
2
23
2
30
9.7%
6.5%
74.2%
6.5%
96.8%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
Count
% of Total
Total
Count
% of Total
Chi-Square Tests
Asymp. Sig. (2Value
Total
0
% of Total
> 200 mg/dl
Membrano
df
sided)
Pearson Chi-Square
9.644a
3
.022
Likelihood Ratio
5.016
3
.171
96
Linear-by-Linear Association
N of Valid Cases
1.205
1
.272
31
a. 7 cells (87.5%) have expected count less than 5. The minimum expected
count is .06.
TG * Biopsi
Crosstab
Biopsi
Minimal
TG
200 mg/dl
Count
% of Total
Total
Count
% of Total
Change
Nefropati
Disease
Membranosa
Focal
Membrano
Segmental
Proliferative
Glomeruloscler Glomeruloneph
osis
ritis
Total
1
1
2
2
6
3.2%
3.2%
6.5%
6.5%
19.4%
0
1
12
0
13
.0%
3.2%
38.7%
.0%
41.9%
2
1
9
0
12
6.5%
3.2%
29.0%
.0%
38.7%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
97
Chi-Square Tests
Asymp. Sig. (2Value
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear Association
N of Valid Cases
df
sided)
12.804a
6
.046
12.397
6
.054
.808
1
.369
31
a. 10 cells (83.3%) have expected count less than 5. The minimum expected
count is .39.
Prot.Urin * Biopsi
Crosstab
98
Biopsi
Focal
Membrano
Segmental
Proliferative
Nefropati
Glomeruloscl Glomerulone
Membranosa
erosis
phritis
Minimal
Change
Disease
Prot.Uri +1
n
Count
% of
Total
+2
Count
% of
Total
+3
Count
% of
Total
+4
Count
% of
Total
Total
Count
% of
Total
Total
0
0
2
0
2
.0%
.0%
6.5%
.0%
6.5%
0
0
3
0
3
.0%
.0%
9.7%
.0%
9.7%
2
2
9
1
14
6.5%
6.5%
29.0%
3.2%
45.2%
1
1
9
1
12
3.2%
3.2%
29.0%
3.2%
38.7%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
99
Chi-Square Tests
Asymp. Sig. (2Value
df
sided)
Pearson Chi-Square
2.661a
9
.976
Likelihood Ratio
3.832
9
.922
.067
1
.797
Linear-by-Linear Association
N of Valid Cases
31
a. 14 cells (87.5%) have expected count less than 5. The minimum expected
count is .13.
Albumin * Biopsi
Crosstab
Biopsi
Focal
Membrano
Segmental Proliferative
Nefropati
Glomerulosc Glomerulone
Membranosa
lerosis
phritis
Minimal
Change
Disease
Albumi < 3,5
n
g/dl
Count
% of
Total
Total
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
100
Total
Count
% of
Total
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
Chi-Square Tests
Value
.a
Pearson Chi-Square
N of Valid Cases
31
a. No statistics are computed because
Albumin is a constant.
Hematuria * Biopsi
Crosstab
Biopsi
Focal
Membrano
Segmental Proliferative
Nefropati Glomerulosc Glomerulone
Membranosa
lerosis
phritis
Minimal
Change
Disease
Hematuri Negatif Count
3
1
18
1
Total
23
101
a
% of
Total
+1
Count
% of
Total
+2
Count
% of
Total
+3
Count
% of
Total
+4
Count
% of
Total
Total
Count
% of
Total
9.7%
3.2%
58.1%
3.2%
74.2%
0
0
1
0
1
.0%
.0%
3.2%
.0%
3.2%
0
0
3
1
4
.0%
.0%
9.7%
3.2%
12.9%
0
1
1
0
2
.0%
3.2%
3.2%
.0%
6.5%
0
1
0
0
1
.0%
3.2%
.0%
.0%
3.2%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
Chi-Square Tests
Asymp. Sig. (2Value
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear Association
df
sided)
17.583a
12
.129
11.860
12
.457
.025
1
.875
102
N of Valid Cases
31
a. 19 cells (95.0%) have expected count less than 5. The minimum expected
count is .06.
Edema * Biopsi
Crosstab
Biopsi
Focal
Membrano
Segmental
Proliferative
Nefropati
Glomeruloscl Glomerulone
Membranosa
erosis
phritis
Minimal
Change
Disease
Edema Ya
Count
% of
Total
Total
Count
% of
Total
Total
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
103
Chi-Square Tests
Value
.a
Pearson Chi-Square
N of Valid Cases
31
a. No statistics are computed because
Edema is a constant.
Ggn.LapangPandang * Biopsi
Crosstab
Biopsi
Minimal
Ggn.LapangPandang
Tidak
Count
% of Total
Ya
Count
% of Total
Total
Count
% of Total
Change
Nefropati
Disease
Membranosa
Focal
Membrano
Segmental
Proliferative
Glomeruloscle Glomerulonep
rosis
hritis
Total
3
3
21
0
27
9.7%
9.7%
67.7%
.0%
87.1%
0
0
2
2
4
.0%
.0%
6.5%
6.5%
12.9%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
104
Chi-Square Tests
Asymp. Sig. (2Value
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear Association
N of Valid Cases
df
sided)
14.751a
3
.002
10.251
3
.017
4.707
1
.030
31
a. 7 cells (87.5%) have expected count less than 5. The minimum expected
count is .26.
ISNA * Biopsi
Crosstab
Biopsi
Focal
Membrano
Segmental
Proliferative
Nefropati
Glomeruloscl Glomerulone
Membranosa
erosis
phritis
Minimal
Change
Disease
ISNA Tidak Count
% of
Total
Ya
Count
Total
0
2
21
2
25
.0%
6.5%
67.7%
6.5%
80.6%
3
1
2
0
6
105
% of
Total
Total
9.7%
3.2%
6.5%
.0%
19.4%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
Count
% of
Total
Chi-Square Tests
Asymp. Sig. (2Value
df
sided)
15.030a
3
.002
Likelihood Ratio
13.053
3
.005
Linear-by-Linear Association
12.814
1
.000
Pearson Chi-Square
N of Valid Cases
31
a. 7 cells (87.5%) have expected count less than 5. The minimum expected
count is .39.
106
Biodata Mahasiswa
Identitas
Nama
:
Yoseph Aditya Dharmawan Suriyanto
NIM
:
22010110110032
Tempat/tanggal lahir :
Semarang, 7 Maret 1992
Jenis kelamin
:
Laki – Laki
Alamat
:
Perum The Hills TamanSari D5/31, Tembalang,
Semarang.
Nomor HP
:
081327020036
Email
:
[email protected]
Riwayat Pendidikan Formal
1. SD
:
SD Santa Maria Purwokerto
Lulus tahun : 2004
2. SMP :
SMP Negeri 1 Purwokerto
Lulus tahun : 2007
3. SMA :
SMA Negeri 1 Purwokerto
Lulus tahun : 2010
4. Fakultas Kedokteran Universitas Diponegoro Masuk tahun: 2010
1. Alatas H, Tambunan T, Trihono P, Pardede SO. Konsensus Tatalaksana
Sindrom Nefrotik Idiopatik pada Anak. Jakarta. Indonesia:2005.
2. Gbadegesin R, Smoyer WE. Dalam: Denis F, Geary, Franz Schaefer,
penyunting. Comprhensive pediatric nephrology. China: Gearysch mosby;
2008. h.205
3. Lane JC. Nephrotic syndrome [serial online]. 12 Mei 2010 [cited 7 Februari
2014].
Didapat
dari:
www.emedicine.medscape.com/article/9892920-
overview
4. Wiguno Prodjosujadi, Divisi Ginjal Hipertensi. Buku Ajar Ilmu Penyakit
Dalam . edisi 4. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam
Fakultas Kedokteran Universitas Indonesia; 2006.
5. Sukandar E, Sulaeman R. Ilmu Penyakit Dalam Jilid II. Jakarta: Balai
Penerbit FKUI;1990. p. 282-305.
6. Orth SR, Ritz E. The Nephrotic Syndrome. N Engl.Med 1998;338:1201-12.
7. Varni J.W., Seid M, Rode C.A. The PedsQLTM measurement model for the
pediatric quality of life inventory.PubMed.1999; 37(2):126-39. Available
from www.ncbi.nlm.nih.gov/pubmed/10024117
70
71
8. Clark A.G, Barratt T.M. Steroid responsive nephrotic syndrome. Dalam: Pine
J.W., penyunting. Pediatric Nephrology. United States of America: Lippincott
Williams&Wilkins; 1999.h.731-45.
9. Otukesh H, Otukesh S, Mojtahedzadeh M, Hoseini R, Fereshtehnejad S.M.,
Riahi A.F. et.al. Management and outcome of steroid-resistant nephrotic
syndrome in children.2009 [cited 24 Januari 2014]. Available from:
http://translate.google.co.id/translate?hl=id&langpair=en|id&u=http://www.ijk
d.org/index.php/ujkd/article/viewFile/122/129
10. Nachman Patrick H, Jannette Charles J., Falk Ronald J. Primary Glomerular
Disease. In: Brenner, Barry M, editors. The Kidney 8th Edition volume 1.
Philadelphia: Saunders Elsevier;2008. p. 1000-03, 1019-28.
11. Wila WIrya IG. Sindrom Nefrotik. Dalam Alatas H, Tambunan T, Trihono P,
Pardede SO. Buku Ajar Nefrologi Anak. Edisi Kedua. Jakarta: Balai Penerbit
FKUI; 2002. h.381-91, 410-22.
12. Appel GB. Glomeruler Disorders and Nephrotic Syndromes. In:Goldman L,
Ausiello D,eds.Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders
Elxevier.2007: chap 122.
13. Kumar Vinay, Cotran Ranzi S., Robbins Stanley L. Buku Ajar Patologi
Volume 2. Edisi 7. Jakarta: Penerbit Buku Kedokteran EGC; 2010.
14. Wijaya Indra, Miranti Ika Pawitra. Patologi Ginjal dan Saluran Kemih.
Semarang: Bagian Patologi Anatomi FK UNDIP;2001.
72
15. Bahiense, Oliviera M, Saldanha LB, Andrade Mota El, et.al. Primary
Glomerular Disease in Brazil: 1979-1999. Is The Frequency of FSGS
increasing? Clin Nephrology. 2004;61: 90-7.
16. Kitiyakana C, Eggers P, Kopp JB. 21 year trend in ESRD due to FSGS in The
United States. Am J Kidney Dis. 2004;44: 815-25.
17. Batinic Danko, Milosevic Danko, Coric Marijana, Scukanec-Spoljar Mira,
Konjevoda Pasko, Batinic Danica et.al. Idiopathic nephritic syndrome in
children: review of 282 Croatian cases. Clinical Nephrology. 2012 ; vol.78No. 2/2012(116-21). Available from: www.dustri.com/nc/article
18. Kanemoto Katsuyoshi, Ito Hidekazu, Anzai Michiko, Matsumura Chieko,
Kurayama Hideaki et.al. Clinical significance of IgM and C1q deposition in
the mesangium in pediatric idiopathic nephritic syndrome. JNephrology.
2013; 26(02):306-14. Available from: www.jnephrol.com/article/clinical-sign
19. D’Agati V. Focal Segmental Glomerulosclerosis. In: D’Agati V, Jannette JC,
Siva FS, eds. Atlas of Non-Tumor Pathology: Nonneoplastic Kidney Disease.
Silver Springer, Md: American Registry of Pathology Brees, 2005: 125-59.
20. Haas M, Maehan S, Karrion TG, Spargo BH. Changing Etiologies of
unexplained adult Nephrotic Syndrome: A Comparison of Renal Biopsy
Finding From 1976-1979 and 1995-1997. Am J Kidney Dis.1997;30:621-31.
21. Aggarwal N, Appel GB. Focal Segmental Glomerulosclerosis. In: Greenberg
A, ed.Primer on Kidney Disease. 5th ed., Philadelphia: WB: Saunder;2009:
165-70.
73
22. Ahmadzedah A, Derakhsan A, Hakimzadeh M, Zolfigol A. Idiopathic
Nephrotic Syndrome in Iranian Children. Indian Pediatrics 2008; 45;52-3.
23. Nasution A., Aumas P. Gambaran Klinis Laboratorium dan Hasil Pengobatan
Sindrom Nefrotik Pada Anak yang dirawat di bagian IKA RSUP Dr. M.
Djamil Padang periode 1997-2000. Disampaikan pada KONIKA XII Bali:
Ikatan Dokter Anak Indonesia;2001.
24. Nilawati G.A.P. Profil Sindrom Nefrotik pada Ruang Perawatan Anak RSUP
Sanglah Denpasar. Denpasar : Departemen Ilmu Kesehatan Anak Fakultas
Kedokteran Universitas Udayana;2012.
25. NiaudetP. Steroid-sensitive idiopathic nephritic syndrome. Dalam: Avner ED,
Harmon WE, NIaudet P. Pediatric nephrology. Edisi ke-5. Philadelphia:
Lippincott Williams&Wilkins;2004.h.545-73.
26. Okoro BA, Okafur HU. Childhood nephrotic syndrome in Enugu, Nigeria.
West Afr J Med 2000; 19:137-41.
74
DAFTAR TILIK PENELUSURAN REKAM MEDIK
Tabel 5. Daftar Tilik Penelusuran Rekam Medik
No.
Keterangan
1.
Nama
2.
Jenis Kelamin
3.
Umur
4.
Berat Badan
5.
Tinggi Badan
6.
Tekanan Darah
140/90
(+)3
(+)4
(+)3
(+)4
75
15.
Hasil Biopsi
76
77
78
79
80
Spreadsheet Data
No.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Jenis
Kelamin
L
P
L
P
L
P
P
L
P
L
L
P
P
P
L
L
L
P
L
L
P
P
L
L
L
L
L
P
L
L
L
TD
(mmHg)
Chol.
(mg/dl)
TG
(mg/dl)
Ggn Lap
Pandang
ISPA
Biopsi
110/60
160/90
115/70
110/80
100/60
120/90
110/80
90/60
120/80
140/100
115/75
150/110
100/70
130/80
114/60
160/100
160/100
117/79
110/70
110/70
110/70
100/60
90/50
110/70
90/50
120/87
100/60
90/60
100/60
120/80
100/65
>200
>200
>200
>200
>200
>200
>200
>200
>200
>200
>200
>200
>200
>200
>200
>200
150-199
>200
>200
150-199
>200
150-199
>200
150-199
200
>200
>200
>200
>200
>200
>200
>200
>200
>200
>200
150-199
150-199
200
200
150-199
>200
>200
150-199
150-199
150-199
3
3
3
150/100
4
12.9
12.9
100.0
31
100.0
100.0
Total
Cholesterol
Cumulative
Frequency
Valid
Percent
Valid Percent
Percent
< 200 mg/dl
1
3.2
3.2
3.2
> 200 mg/dl
30
96.8
96.8
100.0
Total
31
100.0
100.0
TG
Cumulative
Frequency
Valid
200 mg/dl
12
38.7
38.7
Total
31
100.0
100.0
100.0
Prot.Urin
Cumulative
Frequency
Valid
Percent
Valid Percent
Percent
+1
2
6.5
6.5
6.5
+2
3
9.7
9.7
16.1
+3
14
45.2
45.2
61.3
+4
12
38.7
38.7
100.0
Total
31
100.0
100.0
Albumin
Cumulative
Frequency
Percent
Valid Percent
Percent
86
Albumin
Cumulative
Frequency
Valid
< 3,5 g/dl
Percent
31
Valid Percent
100.0
Percent
100.0
100.0
Hematuria
Cumulative
Frequency
Valid
Negatif
Percent
Valid Percent
Percent
23
74.2
74.2
74.2
+1
1
3.2
3.2
77.4
+2
4
12.9
12.9
90.3
+3
2
6.5
6.5
96.8
+4
1
3.2
3.2
100.0
31
100.0
100.0
Total
Edema
Cumulative
Frequency
Valid
Ya
31
Percent
100.0
Valid Percent
100.0
Percent
100.0
87
Ggn.LapangPandang
Cumulative
Frequency
Valid
Tidak
Valid Percent
Percent
27
87.1
87.1
87.1
4
12.9
12.9
100.0
31
100.0
100.0
Ya
Total
Percent
ISNA
Cumulative
Frequency
Valid
Tidak
Valid Percent
Percent
25
80.6
80.6
80.6
6
19.4
19.4
100.0
31
100.0
100.0
Ya
Total
Percent
Biopsi
Cumulative
Frequency
Valid
Percent
Valid Percent
Percent
Minimal Change Disease
3
9.7
9.7
9.7
Nefropati Membranosa
3
9.7
9.7
19.4
88
Focal Segmental
23
74.2
74.2
93.5
2
6.5
6.5
100.0
31
100.0
100.0
Glomerulosclerosis
Membrano Proliferative
Glomerulonephritis
Total
89
Crosstabs
Case Processing Summary
Cases
Valid
N
Missing
Percent
N
Total
Percent
N
Percent
Jenis Kelamin * Biopsi
31
100.0%
0
.0%
31
100.0%
Umur * Biopsi
31
100.0%
0
.0%
31
100.0%
Tekanan Darah * Biopsi
31
100.0%
0
.0%
31
100.0%
Cholesterol * Biopsi
31
100.0%
0
.0%
31
100.0%
TG * Biopsi
31
100.0%
0
.0%
31
100.0%
Prot.Urin * Biopsi
31
100.0%
0
.0%
31
100.0%
Albumin * Biopsi
31
100.0%
0
.0%
31
100.0%
Hematuria * Biopsi
31
100.0%
0
.0%
31
100.0%
Edema * Biopsi
31
100.0%
0
.0%
31
100.0%
Ggn.LapangPandang * Biopsi
31
100.0%
0
.0%
31
100.0%
ISNA * Biopsi
31
100.0%
0
.0%
31
100.0%
Jenis Kelamin * Biopsi
90
Crosstab
Biopsi
Minimal
Jenis Kelamin
Laki-Laki
Change
Nefropati
Disease
Membranosa
Count
% of Total
Perempuan
Count
% of Total
Total
Count
% of Total
Proliferative
rosis
hritis
Total
1
16
1
19
3.2%
3.2%
51.6%
3.2%
61.3%
2
2
7
1
12
6.5%
6.5%
22.6%
3.2%
38.7%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
df
sided)
Pearson Chi-Square
2.748a
3
.432
Likelihood Ratio
2.703
3
.440
Linear-by-Linear Association
1.388
1
.239
31
Segmental
1
Asymp. Sig. (2-
N of Valid Cases
Membrano
Glomeruloscle Glomerulonep
Chi-Square Tests
Value
Focal
91
Chi-Square Tests
Asymp. Sig. (2Value
df
sided)
Pearson Chi-Square
2.748a
3
.432
Likelihood Ratio
2.703
3
.440
Linear-by-Linear Association
1.388
1
.239
N of Valid Cases
31
a. 6 cells (75.0%) have expected count less than 5. The minimum expected
count is .77.
Umur * Biopsi
Crosstab
Biopsi
Focal
Membrano
Segmental Proliferative
Nefropati Glomerulosc Glomerulone
Membranosa
lerosis
phritis
Minimal
Change
Disease
Umur 1-10 tahun Count
% of
Total
11-20
tahun
Count
% of
Total
Total
2
0
13
1
16
6.5%
.0%
41.9%
3.2%
51.6%
1
3
6
0
10
3.2%
9.7%
19.4%
.0%
32.3%
92
21-30
tahun
Count
% of
Total
31-40
tahun
Count
% of
Total
41-50
tahun
Count
% of
Total
51-60
tahun
Count
% of
Total
Total
Count
% of
Total
0
0
1
0
1
.0%
.0%
3.2%
.0%
3.2%
0
0
1
1
2
.0%
.0%
3.2%
3.2%
6.5%
0
0
1
0
1
.0%
.0%
3.2%
.0%
3.2%
0
0
1
0
1
.0%
.0%
3.2%
.0%
3.2%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
Chi-Square Tests
Asymp. Sig. (2Value
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear Association
df
sided)
14.441a
15
.492
12.725
15
.623
.660
1
.417
93
N of Valid Cases
31
a. 22 cells (91.7%) have expected count less than 5. The minimum expected
count is .06.
Tekanan Darah * Biopsi
Crosstab
Biopsi
Minimal
Tekanan Darah 120/80
Count
% of
Focal
Membrano
Segmental
Proliferative
Change
Nefropati
Glomeruloscl
Glomerulonep
Disease
Membranosa
erosis
hritis
Total
3
2
17
1
23
9.7%
6.5%
54.8%
3.2%
74.2%
0
0
3
0
3
.0%
.0%
9.7%
.0%
9.7%
0
0
0
1
1
.0%
.0%
.0%
3.2%
3.2%
0
1
3
0
4
Total
120-139/80-89 Count
% of
Total
140-149/90-99 Count
% of
Total
>150/100
Count
94
% of
.0%
3.2%
9.7%
.0%
12.9%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
Total
Total
Count
% of
Total
Chi-Square Tests
Asymp. Sig. (2Value
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear Association
N of Valid Cases
df
sided)
17.610a
9
.040
9.681
9
.377
.466
1
.495
31
a. 15 cells (93.8%) have expected count less than 5. The minimum expected
count is .06.
Cholesterol * Biopsi
Crosstab
95
Biopsi
Focal
Minimal
Cholesterol
< 200 mg/dl
Segmental
Proliferative
Change
Nefropati
Glomeruloscle
Glomerulonep
Disease
Membranosa
rosis
hritis
Count
1
0
0
1
.0%
3.2%
.0%
.0%
3.2%
3
2
23
2
30
9.7%
6.5%
74.2%
6.5%
96.8%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
Count
% of Total
Total
Count
% of Total
Chi-Square Tests
Asymp. Sig. (2Value
Total
0
% of Total
> 200 mg/dl
Membrano
df
sided)
Pearson Chi-Square
9.644a
3
.022
Likelihood Ratio
5.016
3
.171
96
Linear-by-Linear Association
N of Valid Cases
1.205
1
.272
31
a. 7 cells (87.5%) have expected count less than 5. The minimum expected
count is .06.
TG * Biopsi
Crosstab
Biopsi
Minimal
TG
200 mg/dl
Count
% of Total
Total
Count
% of Total
Change
Nefropati
Disease
Membranosa
Focal
Membrano
Segmental
Proliferative
Glomeruloscler Glomeruloneph
osis
ritis
Total
1
1
2
2
6
3.2%
3.2%
6.5%
6.5%
19.4%
0
1
12
0
13
.0%
3.2%
38.7%
.0%
41.9%
2
1
9
0
12
6.5%
3.2%
29.0%
.0%
38.7%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
97
Chi-Square Tests
Asymp. Sig. (2Value
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear Association
N of Valid Cases
df
sided)
12.804a
6
.046
12.397
6
.054
.808
1
.369
31
a. 10 cells (83.3%) have expected count less than 5. The minimum expected
count is .39.
Prot.Urin * Biopsi
Crosstab
98
Biopsi
Focal
Membrano
Segmental
Proliferative
Nefropati
Glomeruloscl Glomerulone
Membranosa
erosis
phritis
Minimal
Change
Disease
Prot.Uri +1
n
Count
% of
Total
+2
Count
% of
Total
+3
Count
% of
Total
+4
Count
% of
Total
Total
Count
% of
Total
Total
0
0
2
0
2
.0%
.0%
6.5%
.0%
6.5%
0
0
3
0
3
.0%
.0%
9.7%
.0%
9.7%
2
2
9
1
14
6.5%
6.5%
29.0%
3.2%
45.2%
1
1
9
1
12
3.2%
3.2%
29.0%
3.2%
38.7%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
99
Chi-Square Tests
Asymp. Sig. (2Value
df
sided)
Pearson Chi-Square
2.661a
9
.976
Likelihood Ratio
3.832
9
.922
.067
1
.797
Linear-by-Linear Association
N of Valid Cases
31
a. 14 cells (87.5%) have expected count less than 5. The minimum expected
count is .13.
Albumin * Biopsi
Crosstab
Biopsi
Focal
Membrano
Segmental Proliferative
Nefropati
Glomerulosc Glomerulone
Membranosa
lerosis
phritis
Minimal
Change
Disease
Albumi < 3,5
n
g/dl
Count
% of
Total
Total
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
100
Total
Count
% of
Total
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
Chi-Square Tests
Value
.a
Pearson Chi-Square
N of Valid Cases
31
a. No statistics are computed because
Albumin is a constant.
Hematuria * Biopsi
Crosstab
Biopsi
Focal
Membrano
Segmental Proliferative
Nefropati Glomerulosc Glomerulone
Membranosa
lerosis
phritis
Minimal
Change
Disease
Hematuri Negatif Count
3
1
18
1
Total
23
101
a
% of
Total
+1
Count
% of
Total
+2
Count
% of
Total
+3
Count
% of
Total
+4
Count
% of
Total
Total
Count
% of
Total
9.7%
3.2%
58.1%
3.2%
74.2%
0
0
1
0
1
.0%
.0%
3.2%
.0%
3.2%
0
0
3
1
4
.0%
.0%
9.7%
3.2%
12.9%
0
1
1
0
2
.0%
3.2%
3.2%
.0%
6.5%
0
1
0
0
1
.0%
3.2%
.0%
.0%
3.2%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
Chi-Square Tests
Asymp. Sig. (2Value
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear Association
df
sided)
17.583a
12
.129
11.860
12
.457
.025
1
.875
102
N of Valid Cases
31
a. 19 cells (95.0%) have expected count less than 5. The minimum expected
count is .06.
Edema * Biopsi
Crosstab
Biopsi
Focal
Membrano
Segmental
Proliferative
Nefropati
Glomeruloscl Glomerulone
Membranosa
erosis
phritis
Minimal
Change
Disease
Edema Ya
Count
% of
Total
Total
Count
% of
Total
Total
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
103
Chi-Square Tests
Value
.a
Pearson Chi-Square
N of Valid Cases
31
a. No statistics are computed because
Edema is a constant.
Ggn.LapangPandang * Biopsi
Crosstab
Biopsi
Minimal
Ggn.LapangPandang
Tidak
Count
% of Total
Ya
Count
% of Total
Total
Count
% of Total
Change
Nefropati
Disease
Membranosa
Focal
Membrano
Segmental
Proliferative
Glomeruloscle Glomerulonep
rosis
hritis
Total
3
3
21
0
27
9.7%
9.7%
67.7%
.0%
87.1%
0
0
2
2
4
.0%
.0%
6.5%
6.5%
12.9%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
104
Chi-Square Tests
Asymp. Sig. (2Value
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear Association
N of Valid Cases
df
sided)
14.751a
3
.002
10.251
3
.017
4.707
1
.030
31
a. 7 cells (87.5%) have expected count less than 5. The minimum expected
count is .26.
ISNA * Biopsi
Crosstab
Biopsi
Focal
Membrano
Segmental
Proliferative
Nefropati
Glomeruloscl Glomerulone
Membranosa
erosis
phritis
Minimal
Change
Disease
ISNA Tidak Count
% of
Total
Ya
Count
Total
0
2
21
2
25
.0%
6.5%
67.7%
6.5%
80.6%
3
1
2
0
6
105
% of
Total
Total
9.7%
3.2%
6.5%
.0%
19.4%
3
3
23
2
31
9.7%
9.7%
74.2%
6.5%
100.0%
Count
% of
Total
Chi-Square Tests
Asymp. Sig. (2Value
df
sided)
15.030a
3
.002
Likelihood Ratio
13.053
3
.005
Linear-by-Linear Association
12.814
1
.000
Pearson Chi-Square
N of Valid Cases
31
a. 7 cells (87.5%) have expected count less than 5. The minimum expected
count is .39.
106
Biodata Mahasiswa
Identitas
Nama
:
Yoseph Aditya Dharmawan Suriyanto
NIM
:
22010110110032
Tempat/tanggal lahir :
Semarang, 7 Maret 1992
Jenis kelamin
:
Laki – Laki
Alamat
:
Perum The Hills TamanSari D5/31, Tembalang,
Semarang.
Nomor HP
:
081327020036
:
[email protected]
Riwayat Pendidikan Formal
1. SD
:
SD Santa Maria Purwokerto
Lulus tahun : 2004
2. SMP :
SMP Negeri 1 Purwokerto
Lulus tahun : 2007
3. SMA :
SMA Negeri 1 Purwokerto
Lulus tahun : 2010
4. Fakultas Kedokteran Universitas Diponegoro Masuk tahun: 2010